Actualités et Activités de Trinity Biotech
Dirigeants
Voir l'organigramme avec ses 25 principaux dirigeants
Biographies les plus recherchées chez Trinity Biotech
- John Gillard, Chief Executive Officer and Director
- Tom Lindsay, Independent Non-Executive Director
- Jim Walsh, Director
Changements de dirigeants chez Trinity Biotech
- Jerry Lydon, a rejoint l'entreprise comme Head of North America Commercial Operations (publié le 4 mai 2026).
Créer une alerte
pour suivre les mouvements de dirigeants chez Trinity Biotech.
Équipements médicaux
Trinity Biotech a 1 235 concurrents dont Thermo Fisher Scientific (Etats—Unis), Philips (Pays—Bas) et Medtronic (Irlande).
Actualités en fusion/acquisition en Équipements médicaux.
- Niowave vient d'annoncer une levée de fonds de 70 millions de dollars. (publié le 2 juin 2026).
- Le nouveau nom de Edap Tms est FocalTherics. (publié le 1 juin 2026).
- FocalTherics est désormais coté en bourse sous le code FOCL. (publié le 31 mai 2026).
Contacts en Équipements médicaux
Actualités
Derniers communiqués de presse par Trinity Biotech
- Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations - Trinity Biotech plc is a public company, specialising in the development, manufacture and marketing of clinical diagnostic products.
- Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test - Trinity Biotech plc is a public company, specialising in the development, manufacture and marketing of clinical diagnostic products.
- Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren’s Syndrome - Trinity Biotech plc is a public company, specialising in the development, manufacture and marketing of clinical diagnostic produc
- Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System - Trinity Biotech plc is a public company, specialising in the development, manufactur
- Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program - Trinity Biotech plc is a public company, specialising in the development, manufacture and marketing of clinical diagnostic products.
- Trinity Biotech Glucose Monitoring Innovation Achieves Unique Global Recognition: Diabetes Care Premier Hb9210™ HbA1c Analyser Becomes the Only System Awarded Prestigious IFCC Gold Classification for 2026 - Trinity Biotech plc is a public company, special
- Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation - Trinity Biotech plc is a public compa
- Trinity Biotech Regains Compliance with Nasdaq Listing Requirements - Trinity Biotech plc is a public company, specialising in the development, manufacture and marketing of clinical diagnostic products.
- Regulatory Approval Granted for Commencement Of Trinity Biotech’s Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation - Trinity Biotech plc is a public company, specialisin
- Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara™ Preeclampsia Testing Service - Trinity Biotech plc is a public company, specialising in the development, manufacture and marketing of clinical diagnostic products.
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Trinity Biotech
- Trinity Biotech sur Wikipédia, Google News & Yahoo Finance en 1-click
- Trinity Biotech sur LinkedIn, X (Twitter) & YouTube en 1-click
